1. Home
  2. BLCO vs ORA Comparison

BLCO vs ORA Comparison

Compare BLCO & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.36

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Logo Ormat Technologies Inc.

ORA

Ormat Technologies Inc.

HOLD

Current Price

$87.85

Market Cap

5.8B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
ORA
Founded
1853
1965
Country
Canada
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.8B
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
BLCO
ORA
Price
$17.36
$87.85
Analyst Decision
Buy
Buy
Analyst Count
15
13
Target Price
$19.39
★ $126.33
AVG Volume (30 Days)
482.6K
★ 691.4K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
★ 0.54%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.14
Revenue
★ $5,101,000,000.00
$719,267,000.00
Revenue This Year
$7.68
$19.26
Revenue Next Year
$5.95
N/A
P/E Ratio
★ N/A
$78.19
Revenue Growth
★ 6.47
N/A
52 Week Low
$14.44
$85.77
52 Week High
$18.92
$146.39

Technical Indicators

Market Signals
Indicator
BLCO
ORA
Relative Strength Index (RSI) 56.53 40.93
Support Level $16.71 $87.06
Resistance Level $17.54 $93.96
Average True Range (ATR) 0.52 2.47
MACD 0.07 0.22
Stochastic Oscillator 93.10 23.93

Price Performance

Historical Comparison
BLCO
ORA

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.

Share on Social Networks: